Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
$
30.00
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
SKU:
pb-40-3-sheehan
Categories:
Psychopharmacology Bulletin
,
VOL 40 No. 3 Articles
Tags:
aminobutyric-acid-gaba
,
anxiety
,
b-ashok-raj
,
david-v-sheehan
,
juris-janavs
,
kathy-harnett-sheehan
,
mba
,
md
,
panic-disorder
,
phd
,
selective-gaba-reuptake-inhibitor
,
tiagabine
Description
Description
David V. Sheehan, MD
Link
NEGATIVE AND FAILED CLINICAL TRIAL REPORTS
An Open-Label Study of Tiagabine in
Panic Disorder
David V. Sheehan, MD, MBA, Kathy Harnett Sheehan, PhD, B. Ashok Raj, MD, and Juris Janavs, MD
Share On Facebook
Tweet This Product
Pin This Product
Email This Product
Related products
Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD
$
30.00
Add to cart
Details
Charles B. Nemeroff, MD, PhD: The Role of GABA in the Pathophysiology and Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
Asenapine in the Treatment of Bipolar Depression
$
30.00
Add to cart
Details
Cannabis Use and its Association with Psychological Disorders
$
30.00
Add to cart
Details
Page load link
Go to Top
